Status:
COMPLETED
Multicentric European Study In Patients With Vertebral Metastases
Lead Sponsor:
Istituto Ortopedico Rizzoli
Conditions:
Spinal Metastases
Eligibility:
All Genders
18+ years
Brief Summary
Train-METASTRA is a retrospective study that will be performed in order to collect a large and harmonised amount of clinical and imaging data concerning vertebral metastases, focusing in particular on...
Eligibility Criteria
Inclusion
- Alive or dead
- Age 18 -99 years old
- Both male and female
- Diagnosis of cancer metastases at the spine
- Any SINS score
- Admitted for hospitalisation or outpatient visit from Jan 2012 to Dec 2022 N ≥ 1 non-stabilised metastatic vertebra
- Presence of baseline CT scan, and/or MRI and x-rays, showing the presence of metastatic lesions that are not surgically treated
- At least one follow-up visit at ≥ 3 months after the first evaluation or treatment
Exclusion
- Minor patients
- Patients with diagnosis of primary spine tumour, degenerative spinal diseases, deformity or trauma
- Patients without non-stabilised vertebral metastases
- Patients without baseline CT scan or MRI
- Patients without follow up visits
Key Trial Info
Start Date :
February 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2024
Estimated Enrollment :
356 Patients enrolled
Trial Details
Trial ID
NCT06220071
Start Date
February 1 2024
End Date
December 31 2024
Last Update
March 19 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Charite - Universitaetsmedizin Berlin
Berlin, Germany
2
Budai Egeszsegkozpont Zrt
Budapest, Hungary
3
Universitair Medisch Centrum Utrecht
Utrecht, Netherlands